AR057202A1 - Derivados de pirimidina para el tratamiento de crecimiento celular anormal - Google Patents
Derivados de pirimidina para el tratamiento de crecimiento celular anormalInfo
- Publication number
- AR057202A1 AR057202A1 ARP060105269A ARP060105269A AR057202A1 AR 057202 A1 AR057202 A1 AR 057202A1 AR P060105269 A ARP060105269 A AR P060105269A AR P060105269 A ARP060105269 A AR P060105269A AR 057202 A1 AR057202 A1 AR 057202A1
- Authority
- AR
- Argentina
- Prior art keywords
- treatment
- cellular growth
- abnormal cellular
- pirimidine derivatives
- solvates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente se refiere a sales, solvatos y solvatos subestequiométricos de N-[3-[[[2-[(2,3-dihidro-2-oxo-1H-indol-5-il)amino]-5-(trifluorometil)-4-pirimidinil]amino]metil]-2-piridinil]-N-metilmetanosulfonamida. La presente también proporciona composiciones farmacéuticas que comprenden tales complejos, así como procedimientos para tratar crecimiento celular anormal administrando los complejos de la presente.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US74125205P | 2005-12-01 | 2005-12-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR057202A1 true AR057202A1 (es) | 2007-11-21 |
Family
ID=38092618
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP060105269A AR057202A1 (es) | 2005-12-01 | 2006-11-29 | Derivados de pirimidina para el tratamiento de crecimiento celular anormal |
Country Status (7)
Country | Link |
---|---|
US (1) | US8722884B2 (es) |
EP (1) | EP1966192B1 (es) |
JP (2) | JP5134234B2 (es) |
AR (1) | AR057202A1 (es) |
CA (1) | CA2632149C (es) |
TW (1) | TWI374880B (es) |
WO (1) | WO2007063384A2 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2684447C (en) * | 2007-04-18 | 2012-01-24 | Pfizer Products Inc. | Sulfonyl amide derivatives for the treatment of abnormal cell growth |
CA2726508C (en) * | 2008-06-17 | 2016-06-07 | Astrazeneca Ab | Pyridine compounds |
EP2464633A1 (en) | 2009-08-14 | 2012-06-20 | Boehringer Ingelheim International GmbH | Regioselective preparation of 2-amino-5-trifluoromethylpyrimidine derivatives |
US8933227B2 (en) | 2009-08-14 | 2015-01-13 | Boehringer Ingelheim International Gmbh | Selective synthesis of functionalized pyrimidines |
US20120244141A1 (en) | 2010-09-28 | 2012-09-27 | Boehringer Ingelheim International Gmbh | Stratification of cancer patients for susceptibility to therapy with PTK2 inhibitors |
DK2675794T3 (da) | 2011-02-17 | 2019-05-06 | Cancer Therapeutics Crc Pty Ltd | Selektive fak-inhibitorer |
CN103534241B (zh) | 2011-02-17 | 2015-11-25 | 癌症疗法Crc私人有限公司 | Fak抑制剂 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5924990B2 (ja) * | 1979-11-21 | 1984-06-13 | 協和醗酵工業株式会社 | 新規なピペリジン誘導体 |
GB9222700D0 (en) * | 1992-10-29 | 1992-12-09 | Smithkline Beecham Plc | Chemical compounds |
US5795909A (en) * | 1996-05-22 | 1998-08-18 | Neuromedica, Inc. | DHA-pharmaceutical agent conjugates of taxanes |
US6121313A (en) * | 1997-07-29 | 2000-09-19 | Pharmacia & Upjohn Company | Pharmaceutical composition in a form of self-emulsifying formulation for lipophilic compounds |
CH689805A8 (fr) * | 1998-07-02 | 2000-02-29 | Smithkline Beecham Plc | Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant. |
JP2001261654A (ja) * | 2000-03-21 | 2001-09-26 | Mitsui Chemicals Inc | キノリン誘導体およびそれを有効成分として含有する核内レセプター作動薬 |
AU2002336864B2 (en) * | 2001-11-02 | 2006-08-17 | Shire Biochem Inc. | Pharmaceutical compositions for the treatment of leukemia comprising dioxolane nucleosides analogs |
ATE458731T1 (de) * | 2002-12-20 | 2010-03-15 | Pfizer Prod Inc | Pyrimidin-derivate zur behandlung von anormalem zellwachstum |
US7109337B2 (en) | 2002-12-20 | 2006-09-19 | Pfizer Inc | Pyrimidine derivatives for the treatment of abnormal cell growth |
UA80767C2 (en) | 2002-12-20 | 2007-10-25 | Pfizer Prod Inc | Pyrimidine derivatives for the treatment of abnormal cell growth |
MXPA06011658A (es) | 2004-05-14 | 2006-12-14 | Pfizer Prod Inc | Derivados de pirimidina para el tratamiento del crecimiento celular anormal. |
BRPI0510980A (pt) | 2004-05-14 | 2007-11-27 | Pfizer Prod Inc | derivados de pirimidina para o tratamento do crescimento anormal de células |
BRPI0510963A (pt) | 2004-05-14 | 2007-11-20 | Pfizer Prod Inc | derivados pirimidina para o tratamento do crescimento anormal de células |
-
2006
- 2006-11-20 US US12/095,716 patent/US8722884B2/en active Active
- 2006-11-20 CA CA2632149A patent/CA2632149C/en active Active
- 2006-11-20 WO PCT/IB2006/003349 patent/WO2007063384A2/en active Application Filing
- 2006-11-20 EP EP06809250A patent/EP1966192B1/en not_active Not-in-force
- 2006-11-29 AR ARP060105269A patent/AR057202A1/es unknown
- 2006-11-30 TW TW095144504A patent/TWI374880B/zh active
- 2006-11-30 JP JP2006323796A patent/JP5134234B2/ja active Active
-
2012
- 2012-10-02 JP JP2012220359A patent/JP2012255038A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2007063384A3 (en) | 2007-10-04 |
EP1966192B1 (en) | 2012-10-17 |
JP5134234B2 (ja) | 2013-01-30 |
EP1966192A2 (en) | 2008-09-10 |
WO2007063384A2 (en) | 2007-06-07 |
US8722884B2 (en) | 2014-05-13 |
CA2632149C (en) | 2011-11-15 |
CA2632149A1 (en) | 2007-06-07 |
JP2012255038A (ja) | 2012-12-27 |
TW200730507A (en) | 2007-08-16 |
TWI374880B (en) | 2012-10-21 |
JP2007153892A (ja) | 2007-06-21 |
US20110033441A1 (en) | 2011-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY148429A (en) | Novel 1,4-benzothiepin-1,1-dioxide derivatives which are substituted with benzyl groups, method for producing drugs containing said compounds and use thereof | |
AR057202A1 (es) | Derivados de pirimidina para el tratamiento de crecimiento celular anormal | |
ECSP10010419A (es) | Derivados heterocíclicos de urea y métodos de uso de los mismos-211 | |
NO20085176L (no) | Fenyl substituerte heteroaryl-derivater og andvendelse som anti-tumor agenter | |
CL2008002255A1 (es) | Compuesto 3-({4-(2,2-difluoroetil)-3-(1h-pirrolo [2,3-b] piridin-5-il)-1h-pirazol-4-il] pirimidin-2-il}amino)propanonitrilo, inhibidor de raf; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del crecimiento celular anormal o cualquier enfermedad o afeccion mediada por raf. | |
CO6612267A2 (es) | Nuevos derivados de 1,1 dióxido- 5 fenil- 2,3,4-5tetrahidro- 1,4-benzotiazepina y composiciones farmaceúticas que los comprenden | |
ECSP10010654A (es) | Derivados de tienopiridonas como activadores de proteína quinasa activados por amp (ampk) | |
ATE530519T1 (de) | Cyclobutylaminderivate | |
BRPI0911035B8 (pt) | ativadores de pirrolidinona glicoquinase | |
CO6300954A2 (es) | Derivados de tienopiridinonas como activadores de proteina quinasa activados por ampk | |
EA200802007A1 (ru) | Соединения, потенцирующие рецептор амра, и применение указанных соединений в медицине | |
MX2010006893A (es) | Derivados de benzotiazol y benzoxazol y metodos de uso. | |
MX2010009922A (es) | Activadores de piridazinona glucocinasa. | |
NO20082445L (no) | Neuropeptid-2 reseptor-agonister | |
ECSP066883A (es) | Derivados de heteroarilaminopirazol utiles para el tratamiento de la diabetes | |
MX2012004311A (es) | Derivados de ciclohexano spiro condensados como inhibidores de lipasa sensible a hormonas (hsl) utiles en el tratamiento de diabetes. | |
CR11482A (es) | Derivados de 1,2,3-triazol para uso como inhibidores de estearoil-coenzima a desaturasa | |
NO20082096L (no) | Azaindol-2-karboksamidderivativer | |
NI200700316A (es) | Aminopirimidinas como moduladores de la cinasa | |
MX2010002191A (es) | Composiciones y metodos que emplean antagonistas nmda para lograr un efecto anestesico limitado. | |
NO20081905L (no) | Benzotiazolcyklobutylaminderivater og deres anvendelse som histamin-3-reseptorligander | |
ECSP10010664A (es) | Derivados de urea heterocíclicos para el tratamiento de infecciones bacterianas | |
ECSP10010659A (es) | Derivados heterocíclicos de la urea y sus métodos de empleo | |
WO2008104473A3 (en) | Pyrazolopyriidine derivatives and their use as kinase inhibitors | |
CL2009001267A1 (es) | Compuestos derivados de triciclos nitrogenados, con actividad antibacteriana; procedimiento de preparacion; composicion farmceutica que los comprende; para el tratamiento de la tuberculosis. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |